CAJ | 학술논문

目的：调查我医院缺血性脑卒中（ischemic stroke，IS）患者二级预防用药依从性的现状及影响因素。方法采用访谈形式，收集因IS在我院住院的患者出院1年来二级预防用药情况。结果81例我院IS患者中，抗血小板聚集、降脂药的依从性分别为72.8%、49.3%，合并高血压、糖尿病患者降压、降糖药依从性分别为77.6%、70.6%。结论 IS患者二级预防中抗血小板、降脂、降压、降糖药物的应用都未达标，其中降脂药依从性依从性最差。医疗付费方式是影响我院IS患者依从性的独立危险因素。
목적：조사아의원결혈성뇌졸중（ischemic stroke，IS）환자이급예방용약의종성적현상급영향인소。방법채용방담형식，수집인IS재아원주원적환자출원1년래이급예방용약정황。결과81례아원IS환자중，항혈소판취집、강지약적의종성분별위72.8%、49.3%，합병고혈압、당뇨병환자강압、강당약의종성분별위77.6%、70.6%。결론 IS환자이급예방중항혈소판、강지、강압、강당약물적응용도미체표，기중강지약의종성의종성최차。의료부비방식시영향아원IS환자의종성적독립위험인소。
Objective To investigate secondary prevention drug adherence of ischemic stroke (ischemic stroke, IS) patients in our hospital and the influential factors of it. Methods Using interview form to collect medication data of IS patients during the period of 1 year, who were discharged from our hospital. Results In 81 cases patients of our hospital, the adherence of anti-platelet aggregation, lipid-lowering drugs was 72.8%, 49.3%respectively, and the adherence of antihypertensive, antidiabetic drug were 77.6%, 70.6%to patients with hypertension and diabetes. Conclusion The drug adherence of IS patients with antiplatelet, lipid-lowering, antihypertensive, hypoglycemic drug were substandard, and the adherence of lipid-lowering drug is the worst. The medical payment method was independent risk factor affecting drug adherence of patients.